12 October 2010 Last updated at 16:23 ET

Pfizer buys King Pharmaceuticals for $3.6bn

Pfizer sign Pfizer is the world's largest pharmaceutical company by revenue

Related Stories

Drugmaker Pfizer has agreed to buy smaller rival King Pharmaceuticals for $3.6bn (£2.3bn) in cash.

Pfizer is paying $14.25 per share for King, a premium of 40% to King's closing share price on Monday.

King has struggled in recent years as patents on several of its key drugs have expired or been thrown out.

Pfizer said the deal would add about two cents a share to its profit in 2011 and 2012, and three to four cents per share in each of the next three years.

The boards of both companies approved the deal.

King's shares ended Tuesday trading up $3.99 or 39% to $14.14. Pfizer advanced 0.5%.

More on This Story

Related Stories

From other news sites

Related Internet links

The BBC is not responsible for the content of external Internet sites

More Business stories

RSS

Features & Analysis

Elsewhere on BBC News

  • Lake Chapala in Mexico (Pic: Joel Espinosa/Flickr)Crossing borders

    Illegal migration between Mexico and the US is not all one way

Programmes

  • The deep water submarineFast Track Watch

    Pushing the limits of tourism - how much would you pay for a real voyage to the bottom of sea?

bbc.co.uk navigation

BBC © 2012 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.